Literature DB >> 20111897

Recombinant respiratory syncytial virus F protein expression is hindered by inefficient nuclear export and mRNA processing.

Kelly Huang1, Heather Lawlor, Roderick Tang, Randall S MacGill, Nancy D Ulbrandt, Herren Wu.   

Abstract

Studies of the fusion activity of respiratory syncytial virus (RSV) F protein are significantly hindered by low recombinant expression levels. While infection produces F protein levels detectable by western blot, recombinant expression produces undetectable to low levels of F protein. Identifying the obstacles that hinder recombinant F protein expression may lead to improved expression and facilitate the study of F protein function. We hypothesized that nuclear localization and/or inefficient RNA polymerase II-mediated transcription contribute to poor recombinant F protein expression. This study shows a combination of stalled nuclear export, premature polyadenylation, and low mRNA abundance all contribute to low recombinant F protein expression levels. In addition, this study provides an expression optimization strategy that results in greater F protein expression levels than observed by codon-optimization of the F protein gene, which will be useful for future studies of F protein function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20111897     DOI: 10.1007/s11262-010-0449-8

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.198


  53 in total

1.  RhoA interacts with the fusion glycoprotein of respiratory syncytial virus and facilitates virus-induced syncytium formation.

Authors:  M K Pastey; J E Crowe; B S Graham
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.

Authors:  T R Fuerst; E G Niles; F W Studier; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

3.  The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins.

Authors:  P R Johnson; M K Spriggs; R A Olmsted; P L Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

4.  Woodchuck post-transcriptional element induces nuclear export of myotonic dystrophy 3' untranslated region transcripts.

Authors:  Nikolaos P Mastroyiannopoulos; Mariana L Feldman; James B Uney; Mani S Mahadevan; Leonidas A Phylactou
Journal:  EMBO Rep       Date:  2005-05       Impact factor: 8.807

5.  Respiratory syncytial virus F envelope protein associates with lipid rafts without a requirement for other virus proteins.

Authors:  Elisa H Fleming; Andrey A Kolokoltsov; Robert A Davey; Joan E Nichols; Norbert J Roberts
Journal:  J Virol       Date:  2006-09-27       Impact factor: 5.103

6.  Cloning and expression of cDNAs from hepatitis E virus structural gene.

Authors:  Bing Ruan; Edward Zumbika; Shu-Ying Wang; Yong Chen; Yi-Lin Ma; Ya-Gang Chen; Ke-Zhou Liu
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2003-08

7.  Rabies virus glycoprotein expression in Drosophila S2 cells. I: design of expression/selection vectors, subpopulations selection and influence of sodium butyrate and culture medium on protein expression.

Authors:  Marcos Alexandre Nobre Lemos; Alexandra Souza Dos Santos; Renato Mancini Astray; Carlos Augusto Pereira; Soraia Attie Calil Jorge
Journal:  J Biotechnol       Date:  2009-07-15       Impact factor: 3.307

8.  Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract.

Authors:  Herren Wu; David S Pfarr; Syd Johnson; Yambasu A Brewah; Robert M Woods; Nita K Patel; Wendy I White; James F Young; Peter A Kiener
Journal:  J Mol Biol       Date:  2007-02-20       Impact factor: 5.469

9.  Role of the hepatitis B virus posttranscriptional regulatory element in export of intronless transcripts.

Authors:  Z M Huang; T S Yen
Journal:  Mol Cell Biol       Date:  1995-07       Impact factor: 4.272

10.  Structure and function study of paramyxovirus fusion protein heptad repeat peptides.

Authors:  Xiao-Jia Wang; Ya-Duo Bai; Guo-Zhong Zhang; Ji-Xun Zhao; Ming Wang; George F Gao
Journal:  Arch Biochem Biophys       Date:  2005-04-15       Impact factor: 4.013

View more
  7 in total

1.  Novel vaccine regimen elicits strong airway immune responses and control of respiratory syncytial virus in nonhuman primates.

Authors:  Thomas Grunwald; Matthias Tenbusch; Reiner Schulte; Katharina Raue; Hans Wolf; Drew Hannaman; Rik L de Swart; Klaus Uberla; Christiane Stahl-Hennig
Journal:  J Virol       Date:  2014-01-22       Impact factor: 5.103

Review 2.  Targeting RSV with vaccines and small molecule drugs.

Authors:  Heather M Costello; William C Ray; Supranee Chaiwatpongsakorn; Mark E Peeples
Journal:  Infect Disord Drug Targets       Date:  2012-04

3.  Reverse genetics systems for contemporary isolates of respiratory syncytial virus enable rapid evaluation of antibody escape mutants.

Authors:  Wendy K Jo; Alina Schadenhofer; Andre Habierski; Franziska K Kaiser; Giulietta Saletti; Tina Ganzenmueller; Elias Hage; Sibylle Haid; Thomas Pietschmann; Gesine Hansen; Thomas F Schulz; Guus F Rimmelzwaan; Albert D M E Osterhaus; Martin Ludlow
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-06       Impact factor: 11.205

4.  A stabilized respiratory syncytial virus reverse genetics system amenable to recombination-mediated mutagenesis.

Authors:  Anne L Hotard; Fyza Y Shaikh; Sujin Lee; Dan Yan; Michael N Teng; Richard K Plemper; James E Crowe; Martin L Moore
Journal:  Virology       Date:  2012-10-11       Impact factor: 3.616

5.  A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models.

Authors:  Stacie L Lambert; Shahin Aslam; Elizabeth Stillman; Mia MacPhail; Christine Nelson; Bodrey Ro; Rosemary Sweetwood; Yuk Man Lei; Jennifer C Woo; Roderick S Tang
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

6.  RSV Vaccine Based on Rhabdoviral Vector Protects after Single Immunization.

Authors:  Sarah Wilmschen; Sabrina Schneider; Felix Peters; Lea Bayer; Leila Issmail; Zoltán Bánki; Thomas Grunwald; Dorothee von Laer; Janine Kimpel
Journal:  Vaccines (Basel)       Date:  2019-07-03

7.  RAGE inhibits human respiratory syncytial virus syncytium formation by interfering with F-protein function.

Authors:  Jane Tian; Kelly Huang; Subramaniam Krishnan; Catherine Svabek; Daniel C Rowe; Yambasu Brewah; Miguel Sanjuan; Andriani C Patera; Roland Kolbeck; Ronald Herbst; Gary P Sims
Journal:  J Gen Virol       Date:  2013-04-04       Impact factor: 3.891

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.